Hospital for Sick Children, Toronto
Fellowship in New Agents and Innovative Therapies (NAIT) and/or Neuroblastoma
Starting July 2023
The Hospital for Sick Children (www.sickkids.ca) is the largest children’s hospital in Canada and has a world-leading oncology program. We are seeking applicants for a 1-2 year fellowship in our early phase clinical trials program (NAIT) and/or neuroblastoma starting July 2023.
On average, our Phase 1 Program has 20 to 25 patients per year and additional local, national and international consultations, including patients with relapsed or refractory leukaemias/solid tumours/brain tumours. The Hospital for Sick Children has the largest Paediatric Oncology Developmental Therapeutics Program in Canada and participates in multiple industry sponsored and investigator-initiated trials, as well as those from academic consortia such as NANT (neuroblastoma), PBTC (neuro-oncology) and Ped-CITN (immunotherapy). An MIBG therapeutic facility opened at SickKids in early 2014 and the hospital also has a very active Cellular Therapy program for cancers.
Our Neuroblastoma Program has approximately 25 new patients per year and additional local, national and international consultations, including patients with refractory neuroblastoma and genetic predisposition to neuroblastoma.
The fellowship program and relative duration for each component may be personalized to the interests of the applicant. Successful candidates will participate in on-call coverage, most commonly weekend daytime coverage on the in-patient haematology/oncology ward. Applicants should indicate their primary interests and may apply for either NAIT or neuroblastoma fellowship, or for a combined role.
Informal enquiries prior to application are welcome; please email: daniel.morgenstern@sickkids.ca.
Please complete online application here: https://surveys.sickkids.ca/surveys/?s=spDYhiN7Qm
Application deadline: Sunday 3 July 2022.